HBV
HBV inhibitors are compounds designed to target and inhibit various stages of the Hepatitis B virus (HBV) lifecycle. These inhibitors can interfere with viral replication, assembly, or release, thereby reducing the viral load and helping to manage chronic HBV infections. Research into HBV inhibitors is crucial for developing effective antiviral therapies to prevent liver disease and cancer associated with HBV. At CymitQuimica, we offer a range of HBV inhibitors to support your research in virology, antiviral drug development, and infectious disease management.
Found 187 products of "HBV"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Hepatitis b virus pre-s region (120-145)
CAS:Hepatitis B Virus Pre-S Region (120-145) is a preS2 peptide that effectively blocks the attachment of single-chain Fv fragment (scFv) or IgG to recombinantFormula:C135H199N39O38SColor and Shape:SolidMolecular weight:3008.33HBV-IN-45
HBV-IN-45 is a selective and orally bioavailable HBV capsid assembly modulator, with an IC50 of 0.51 μM for HBcAg in HBC cells. [HBV-IN-45] demonstrates potent anti-HBV activity.Formula:C16H16N2O2SMolecular weight:300.093253'-DMTr-dG(iBu)
CAS:'3'-DMTr-dG(iBu) is a nucleoside used in antiviral research and to combat Alzheimer's and other tauopathies.Formula:C44H54N7O8PColor and Shape:SolidMolecular weight:839.92(Tetrahydro-2H-pyran-4-yl)methanol
CAS:Compound Fr13803, with CAS No. 14774-37-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13803 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.Formula:C6H12O2Purity:98.73%Molecular weight:116.16FNC-TP
CAS:FNC-TP, an active FNC form, is a strong NRTI with anti-HIV, HBV, HCV effects.Formula:C9H14FN6O13P3Color and Shape:SolidMolecular weight:526.16HBV-IN-37
CAS:HBV-IN-37, an HBV inhibitor with 10 μM EC50, may treat hepatitis B.Formula:C23H22ClN3O2SPurity:99.8%Color and Shape:SolidMolecular weight:439.96Bulevirtide
CAS:Bulevirtide (Myrcludex B) inhibits HBV/HDV entry into hepatocytes, treating chronic hepatitis D.Formula:C248H355N65O72Purity:98%Color and Shape:SolidMolecular weight:5398.86KR019
KR019 is a potent hepatitis B virus (HBV) capsid assembly modulator that demonstrates significant antiviral activity in HBV cells. It binds to the hydrophobic pocket at the core protein dimer-dimer interface, redirecting capsid assembly into genome-free capsids, thereby inhibiting viral replication.Color and Shape:Odour SolidFirzacorvir
CAS:Firzacorvir is a cyclic sulfamide compound that acts as an HBV core protein modulator and exhibits potent anti-HBV activity, with an EC50 value of < 1 μΜ.Formula:C18H18ClFN6O3S2Color and Shape:SolidMolecular weight:484.95Anti-Viral Compound Library
A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;Color and Shape:Odour SolidRef: TM-L1700
1mgTo inquire30μL*10mM (DMSO)To inquire50μL*10mM (DMSO)To inquire100μL*10mM (DMSO)To inquire250μL*10mM (DMSO)To inquireHBV/HDV-IN-4 hydrochloride
CAS:HBV/HDV-IN-4 hydrochloride (Compd 4) serves as an inhibitor of both HBV and HDV, demonstrating an EC 50 of less than 50 nM against HBV.Formula:C35H39BrClF3N6O7Molecular weight:828.07Elebsiran
CAS:Elebsiran is an antiviral agent [1] .Formula:C485H658F9N158O294P39S6Color and Shape:SolidMolecular weight:14976.62Xalnesiran sodium
CAS:Xalnesiran (sodium) is siRNA for the treatment of chronic hepatitis B ( HBV )..Formula:C664H814F17N231Na57O415P57S6Color and Shape:SolidMolecular weight:22262.12BAY38-7690
CAS:BAY38-7690, a hepatitis B virus inhibitor, may have potential for future therapeutic regimens to combat chronic HBV infection.Formula:C19H16ClF2N3O2Color and Shape:SolidMolecular weight:391.8Destruxin B2
CAS:Destruxin B2, found in M. anisopliae, has antiviral, insecticidal properties, inhibits HBsAg (IC50=1.3 μM), and is toxic to Sf9 cells (ECIS50=92 μM).Formula:C29H49N5O7Color and Shape:SolidMolecular weight:579.739Elebsiran sodium
Elebsiran sodium is an siRNA targeting hepatitis B and D virus infections [1].Color and Shape:Odour SolidJunceellolide C
CAS:Junceellolide C: transcription inhibitor of cccDNA, curbs HBV DNA replication, EC50 of 5.19 & 3.52μM in HepAD38 cells, potent anti-HBV.Formula:C26H33ClO10Color and Shape:SolidMolecular weight:540.99Angeloylgomisin P
CAS:Angeloylgomisin P is a useful organic compound for research related to life sciences. The catalog number is T124224 and the CAS number is 77881-08-4.Formula:C28H34O9Color and Shape:SolidMolecular weight:514.571PROTAC HBeAg degrader-1
PROTACHBeAg degrader-1 is a PROTAC-based targeted degrader of HBeAg. It effectively recruits the VHL E3 ligase, yet its ability to degrade the hepatitis B virus protein (HBeAg) does not depend on VHL recruitment. This compound decreases levels of both secreted and intracellular HBeAg and is suitable for research involving the hepatitis B virus (HBV).Color and Shape:Odour SolidAntiviral agent
CAS:Antiviral agent is thiazolidin-4-one with anti-hepatitis B activityFormula:C20H21N3O2S2Purity:99.87%Color and Shape:SoildMolecular weight:399.53Ref: TM-T67904
1mL*10mM (DMSO)To inquire1mg109.00€5mg241.00€10mg354.00€25mg532.00€50mg745.00€100mg1,018.00€500mg2,035.00€
